Myant Corp., a leader in chronic disease prevention through precision medicine, announced the acquisition of mmHg Inc., a digital health company specializing in remote...
Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced that it has raised $34 million in Series...
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announces an expansion to its collaboration...
BIOMAKERS, a Precision Medicine & Biotech Company that supports data-driven Drug Development globally, and TOPAZIUM, an AI-driven healthtech company specializing in drug discovery and human...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced the launch of a new program specifically geared towards using algorithms to...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced an expanded collaboration with Remix Therapeutics, a clinical-stage biotechnology company developing small...